Kelly C, LaMont J.
– more difficult than ever. N Engl J Med
; 359: 1932–40.
Zilberberg M, Shorr A, Kollef M.
Increase in adult Clostridium difficile
related hospitalizations and case-fatality rate, United States, 2000–2005. Emerg Infect Dis
; 14: 929–31.
Lawrence S, Puzniak L, Shadel B, Gillespie K, Kollef M, Mundy L.
in the intensive care unit: epidemiology, costs, and colonization pressure. Infect Control Hosp Epidemiol
; 28: 123–30.
McGregor A, Riley T, VanGessel H. Clostridium difficile associated disease
. In Cruickshank M, Ferguson J., editor. Reducing Harm to Patients from Healthcare Associated Infection: The Role of Surveillance. Sydney: Australian Commission on Safety and Quality in Healthcare; 2008.
Dial SMDM, Kezouh AP, Dascal AMD, Barkun AMDM, Suissa SP.
Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile
; 179: 767–72.
From obscurity to ‘superbug’ – The rise of Clostridium difficile
. Healthc Infect
; 15: 59–61.
Mitchell B, McGregor A, Brown S. Clostridium difficile infection surveillance protocol V2.0
.: Department of Health and Human Services; 2009 [cited 2010 1st June 2010]; Available from: http://www.dhhs.tas.gov.au/health_and_wellbeing/public_and_environmental_health/related_topics/tasmanian_infection_prevention_and_control_unit/publications/CDI_Surveillance_Protocol_V2.0_August_2009.pdf
Australian Commission on Safety and Quality in Healthcare. Data Dictionary and Collection Guidelines for the Surveillance of Healthcare Associated Infections: Staphylococcus aureus bacteraemia & Clostridium difficile Infection
. Australian Commission on Safety and Quality in Healthcare; 2010 [cited 2010 1st December]; V3.0: [Available from: http://www.health.gov.au/internet/safety/publishing.nsf/Content/com-pubs_HAI-NatSurv-DraftDataDic
McDonald C, Coignard B, Dubberke E, Song X, Horan T, Kutty P.
Recommendations for Surveillance of Clostridium difficile
–Associated Disease. Infect Control Hosp Epidemiol
; 28: 140–5.
Mitchell B, McGregor A. Microbiology laboratory testing for Clostridium difficile
in Tasmania. In Ware C, editor. Hobart: Department of Health and Human Services; 2010.
Price MF, Dao-Tran T, Garey KW, Graham G, Gentry LO, Dhungana L,
Epidemiology and incidence of Clostridium difficile
-associated diarrhoea diagnosed upon admission to a university hospital. J Hosp Infect
; 65: 42–6.
Van Gessel H.
Measuring the incidence of Clostridium difficile
-associated diarrhoea in a group of Western Australian hospitals. Healthc Infect
; 13: 56–62.
Elliott B, Chang BJ, Golledge CL, Riley TV.
-associated diarrhoea. Intern Med J
; 37: 561–8.
Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S,
A predominantly clonal multi-institutional outbreak of Clostridium difficile
-associated diarrhea with high morbidity and mortality. N Engl J Med
; 353: 2442–9.
Thomas C, Stevenson M, Williamson D, Riley T.
associated diarrhoea: epidemiological data from Western Australia associated with a modified antibiotics policy. Clin Infect Dis
; 35: 1457–62.
Sohn S, Climo M, Diekema D, Fraser V, Herwaldt L, Marino S,
Varying Rates of Clostridium difficile
Associated Diarrhea at Prevention Epicenter Hospitals. Infect Control Hosp Epidemiol
; 26: 676–9.
Health Protection Agency. Results of the mandatory Clostridium difficile reporting scheme – Acute Trust Counts and Rates by Quarter and Financial year- April 2007 onwards
. London: Health Protection Agency; 2010 [cited 2010 3rd September 2010]; Available from: http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1278944234025
Van Gessel H, Riley T, McGregor A.
infection: an update for infection control practitioners. Healthc Infect
; 14: 115–8.
Jarvis WR, Schlosser JA, Jarvis AA, Chinn RY.
National point prevalence of Clostridium difficile in US health care facility inpatients, 2008. Am J Infect Control
; 37: 263–70.
Lambert PJ, Dyck M, Thompson LH, Hammond GW.
Population based surveillance of Clostridium difficile
infection in Manitoba, Canada, by using interim surveillance definitions. Infect Control Hosp Epidemiol
; 30: 945–51.
Paltansing S, Van Den Berg RJ, Guseinova RA, Visser CE, Van Der Vorm ER, Kuijper EJ.
Characteristics and incidence of Clostridium difficile
-associated disease in The Netherlands, 2005. Clin Microbiol Infect
; 13: 1058–64.
Asensio A, Vaque-Rafart J, Calbo-Torrecillas F, Gestal-Otero J, López-Fernández F, Trilla-Garcia A, Canton R.
Increasing rates in Clostridium Difficile
infection (CDI) among hospitalised patients, Spain 1999–2007. Eurosurveillance
; 13: 18 943.
Barbut F, Gariazzo B, Bonne L, Lalande V, Burghoffer B, Luiuz R,
Clinical features of Clostridium difficile
-associated infections and molecular characterization of strains: results of a retrospective study, 2000–2004. Infect Control Hosp Epidemiol
; 28: 131–9.
Health Protection Agency (2011). Voluntary surveillance of Clostridium difficile
in England, Wales and Northern Ireland, 2010. http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1296681242219